Boditech Med Inc. (KOSDAQ:206640)

South Korea · Delayed Price · Currency is KRW

11,570

+330 (2.94%)

Aug 11, 2026, 3:17 PM KST

-17.24% (1Y)

Market Cap	228.68B -24.9%
Revenue (ttm)	165.84B +15.0%
Net Income	25.99B -6.7%
EPS	1,200.55 -5.6%
Shares Out	20.34M
PE Ratio	9.36
Forward PE	n/a
Dividend	150.00 (1.36%)
Ex-Dividend Date	Mar 31, 2026

Volume	32,149
Open	11,160
Previous Close	11,240
Day's Range	11,100 - 11,770
52-Week Range	9,580 - 15,000
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 541

Stock Exchange KOSDAQ

Ticker Symbol 206640

Full Company Profile

Financial Performance

In 2025, Boditech Med's revenue was 162.09 billion, an increase of 17.32% compared to the previous year's 138.16 billion. Earnings were 23.65 billion, a decrease of -13.23%.

Financial Statements